Johnson & Johnson’s latest earnings bested Wall Street estimates, as the company braces for one of its top-selling medicines ...

Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a standalone ...

Johnson & Johnson is one of several Dow Jones Industrial Average stocks reporting financial results this week. A look at the ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a ...

Barclays lowered the firm’s price target on Johnson & Johnson to $159 from $160 and keeps an Equal Weight rating on the shares. The firm ...